Latest Breaking News On - Biological sample - Page 7 : vimarsana.com

Europe is seeing a hiring boom in clinical trial operations industry fintech roles

Europe is seeing a hiring boom in clinical trial operations industry fintech roles
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

Noord brabantUnited statesSample servicesCellular immuneRegulatory consultationClinical supplyBiological sample

How is fintech innovation progressing in the clinical trial operations industry?

How is fintech innovation progressing in the clinical trial operations industry?
clinicaltrialsarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from clinicaltrialsarena.com Daily Mail and Mail on Sunday newspapers.

United statesSouth koreaCentric services forElectronic data capture solutions for clinical trialsHanmi science co ltdSample servicesUnited bio pharma incPfizer incBridgebio pharma incCentric servicesAlternate site clinical trialsClinical supplyBiological sampleData capture solutions

Skye retains CMAX Clinical Research for Phase I glaucoma treatment trial

Skye Bioscience has retained CMAX clinical Research for Phase I trial of its SBI-100 OE being developed for potential treatment of glaucoma.

United kingdomSouth australiaSkye bioscienceTu diepCentric services forDrug administrationSample servicesRegulatory agencyAustralian therapeutic goods administrationNovotech healthContract manufacturing organisationClinical researchEuropean medicines agencyGood clinical practiceUnited kingdom medicinesProfessor shakib

Alterity receives MHRA authorisation for Phase II trial of MSA therapy

Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.

United statesNew zealandUnited kingdomDavid stamlerElectronic data capture solutions for clinical trialsEuropean commissionDrug administrationSample servicesRegulatory agencyAlterity therapeuticsMultiple system atrophyUnited kingdom medicinesCellular immuneClinical supplyBiological sampleData capture solutions

Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy

Priothera has announced plans to commence Phase IIb/III trial of mocravimod in acute myeloid leukaemia patients undergoing allogeneic HSCT.

Florent grosSaas platform decentralizing clinical research at scaleDrug administrationTime data services for clinical researchSample servicesInvestigational new drugClinical supplyBiological sampleTime data servicesClinical research